Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock ...
Net Revenue: $154.6 million for Q1 2024, a 30% year-over-year growth. Net Revenue Guidance for 2024: Projected to be between $700 million to $720 million. Net Income: Non-GAAP adjusted net income for ...